Document
IPR2017-00645, No. 1017 Exhibit - Mylan EX 1017 Chong Min Won Excerpt (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1017 Exhibit - Mylan EX 1017 Chong Min Won Excerpt (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1026 Exhibit - Mylan EX 1026 Amendment and Response dated December 23, 2014 (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1026 Exhibit - Mylan EX 1026 Amendment and Response dated December 23, 2014 (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1037 Exhibit - Mylan EX 1037 Amendment and Response dated August 9, 2013 (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1037 Exhibit - Mylan EX 1037 Amendment and Response dated August 9, 2013 (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1016 Exhibit - Mylan EX 1016 Shah et al, Excerpt (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1016 Exhibit - Mylan EX 1016 Shah et al, Excerpt (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1007 Exhibit - Mylan EX 1007 APP Levothyroxine Sodium (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1007 Exhibit - Mylan EX 1007 APP Levothyroxine Sodium (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1003 Exhibit - Mylan EX 1003 US Patent No 9,168,239 (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1003 Exhibit - Mylan EX 1003 US Patent No 9,168,239 (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1001 Exhibit - Mylan EX 1001 US Patent No 9,006,289 (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1001 Exhibit - Mylan EX 1001 US Patent No 9,006,289 (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1006 Exhibit - Mylan EX 1006 Abbott Synthroid¿¿ Prescribing Info (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1006 Exhibit - Mylan EX 1006 Abbott Synthroid¿¿ Prescribing Info (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1014 Exhibit - Mylan EX 1014 Declaration of Jiang et al, dated August 7, 2013 (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1014 Exhibit - Mylan EX 1014 Declaration of Jiang et al, dated August 7, 2013 (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1035 Exhibit - Mylan EX 1035 Amendment and Response dated June 6, 2014 (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1035 Exhibit - Mylan EX 1035 Amendment and Response dated June 6, 2014 (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1018 Exhibit - Mylan EX 1018 Brower et al, Excerpt (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1018 Exhibit - Mylan EX 1018 Brower et al, Excerpt (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1013 Exhibit - Mylan EX 1013 Declaration of Arunya Usayapant dated December 23, 2014 (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1013 Exhibit - Mylan EX 1013 Declaration of Arunya Usayapant dated December 23, 2014 (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1015 Exhibit - Mylan EX 1015 Declaration of Leonard J Chyall dated June 5, 2014 (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1015 Exhibit - Mylan EX 1015 Declaration of Leonard J Chyall dated June 5, 2014 (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1039 Exhibit - Mylan EX 1039 Richard J Lewis, Sr, Hawley¿¿¿s Condensed Chemical Dictionary (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1039 Exhibit - Mylan EX 1039 Richard J Lewis, Sr, Hawley¿¿¿s Condensed Chemical Dictionary (P.T.A.B. Jan. 19, 2017)
+ More Snippets
Document
IPR2017-00645, No. 1034 Exhibit - Mylan EX 1034 Prescribing Info Levothyroxine Sodium (P.T.A.B. Jan. 19, 2017)
Cite Document
IPR2017-00645, No. 1034 Exhibit - Mylan EX 1034 Prescribing Info Levothyroxine Sodium (P.T.A.B. Jan. 19, 2017)
+ More Snippets